Parallel algorithm for myeloproliferative neoplasms testing: the frequency of double mutations is found in the JAK2/MPL genes more often than the JAK2/CALR genes, but is there a clinical benefit?

Clin Chem Lab Med. 2019 Mar 26;57(4):e60-e62. doi: 10.1515/cclm-2018-0232.

Aleksey S Gorbenko¹, Marina A Stolyar^{1

2}, Igor A Olkhovskiy^{3

4}, Evgeniy V Vasiliev⁵, Mikhail A Mikhalev⁶

¹ Krasnoyarsk Branch of the "National Research Center for Hematology" Department of Health, Krasnoyarsk, Russian Federation.
² Siberian Federal University, Krasnoyarsk, Russian Federation.
³ Krasnoyarsk Branch of the "National Research Center for Hematology" Department of Health, Akademgorodok 50/45, Krasnoyarsk 660036, Russian Federation.
⁴ Federal Research Center Krasnoyarsk Scientific Center of the Siberian Branch of the Russian Academy of Sciences, Krasnoyarsk, Russian Federation.
⁵ Krasnoyarsk Regional Clinic Hospital, Krasnoyarsk, Russian Federation.
⁶ Krasnoyarsk City Clinical Hospital No. 7, Krasnoyarsk, Russian Federation.

No abstract available

Keywords: CALR; JAK2; MPL; myeloproliferative neoplasms; somatic mutations.

Publication types